rs186367879

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012418.4(FSCN2):​c.967G>A​(p.Ala323Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0325 in 1,530,642 control chromosomes in the GnomAD database, including 908 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 66 hom., cov: 31)
Exomes 𝑓: 0.033 ( 842 hom. )

Consequence

FSCN2
NM_012418.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.815

Publications

9 publications found
Variant links:
Genes affected
FSCN2 (HGNC:3960): (fascin actin-bundling protein 2, retinal) This gene encodes a member of the fascin protein family. Fascins crosslink actin into filamentous bundles within dynamic cell extensions. This family member is proposed to play a role in photoreceptor disk morphogenesis. A mutation in this gene results in one form of autosomal dominant retinitis pigmentosa and macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
FSCN2 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa 30
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032982528).
BP6
Variant 17-81535192-G-A is Benign according to our data. Variant chr17-81535192-G-A is described in ClinVar as [Benign]. Clinvar id is 402883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0256 (3891/151798) while in subpopulation NFE AF = 0.0375 (2545/67880). AF 95% confidence interval is 0.0363. There are 66 homozygotes in GnomAd4. There are 1883 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 3891 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FSCN2NM_012418.4 linkc.967G>A p.Ala323Thr missense_variant Exon 2 of 5 ENST00000417245.7 NP_036550.1 O14926-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FSCN2ENST00000417245.7 linkc.967G>A p.Ala323Thr missense_variant Exon 2 of 5 1 NM_012418.4 ENSP00000388716.2 O14926-1
FSCN2ENST00000334850.7 linkc.967G>A p.Ala323Thr missense_variant Exon 2 of 5 5 ENSP00000334665.7 O14926-2

Frequencies

GnomAD3 genomes
AF:
0.0257
AC:
3892
AN:
151680
Hom.:
66
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00669
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.0276
Gnomad ASJ
AF:
0.0613
Gnomad EAS
AF:
0.000388
Gnomad SAS
AF:
0.00623
Gnomad FIN
AF:
0.0281
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0375
Gnomad OTH
AF:
0.0360
GnomAD2 exomes
AF:
0.0267
AC:
3616
AN:
135440
AF XY:
0.0264
show subpopulations
Gnomad AFR exome
AF:
0.00559
Gnomad AMR exome
AF:
0.0223
Gnomad ASJ exome
AF:
0.0569
Gnomad EAS exome
AF:
0.0000998
Gnomad FIN exome
AF:
0.0252
Gnomad NFE exome
AF:
0.0395
Gnomad OTH exome
AF:
0.0316
GnomAD4 exome
AF:
0.0332
AC:
45783
AN:
1378844
Hom.:
842
Cov.:
31
AF XY:
0.0328
AC XY:
22346
AN XY:
680324
show subpopulations
African (AFR)
AF:
0.00669
AC:
210
AN:
31394
American (AMR)
AF:
0.0224
AC:
789
AN:
35148
Ashkenazi Jewish (ASJ)
AF:
0.0580
AC:
1449
AN:
24996
East Asian (EAS)
AF:
0.0000566
AC:
2
AN:
35328
South Asian (SAS)
AF:
0.00689
AC:
542
AN:
78636
European-Finnish (FIN)
AF:
0.0264
AC:
900
AN:
34042
Middle Eastern (MID)
AF:
0.0545
AC:
309
AN:
5668
European-Non Finnish (NFE)
AF:
0.0369
AC:
39716
AN:
1075972
Other (OTH)
AF:
0.0324
AC:
1866
AN:
57660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1957
3914
5872
7829
9786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1482
2964
4446
5928
7410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0256
AC:
3891
AN:
151798
Hom.:
66
Cov.:
31
AF XY:
0.0254
AC XY:
1883
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.00667
AC:
276
AN:
41362
American (AMR)
AF:
0.0275
AC:
419
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.0613
AC:
213
AN:
3472
East Asian (EAS)
AF:
0.000389
AC:
2
AN:
5138
South Asian (SAS)
AF:
0.00624
AC:
30
AN:
4810
European-Finnish (FIN)
AF:
0.0281
AC:
297
AN:
10574
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0375
AC:
2545
AN:
67880
Other (OTH)
AF:
0.0356
AC:
75
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0351
Hom.:
269
Bravo
AF:
0.0248
TwinsUK
AF:
0.0372
AC:
138
ALSPAC
AF:
0.0371
AC:
143
ESP6500AA
AF:
0.00506
AC:
7
ESP6500EA
AF:
0.0361
AC:
115
ExAC
AF:
0.0151
AC:
411
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T;.
Eigen
Benign
0.068
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.87
D;D
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
M;M
PhyloP100
0.81
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-2.3
N;N
REVEL
Benign
0.093
Sift
Uncertain
0.014
D;D
Sift4G
Benign
0.16
T;T
Polyphen
0.65
P;.
Vest4
0.34
MPC
0.20
ClinPred
0.0091
T
GERP RS
3.9
Varity_R
0.18
gMVP
0.39
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186367879; hg19: chr17-79502218; COSMIC: COSV106100171; COSMIC: COSV106100171; API